Letrozol 2.5

ACTIVE HALF-LIFE 2 days
CLASSIFICATION Non-steroidal aromatase inhibitor
DOSAGE 2.5 mg/day
ACNE No
WATER RETENTION No
HBR No
HEPATOTOXICITY No
AROMATIZATION No
MANUFACTURER Nakon Medical
LAB TEST See Document
WAREHOUSE International Warehouse 3
SUBSTANCE Letrozole ,

Letrozol 2.5, produced by Nakon Medical, is an anti-estrogen medication widely used in medical and sports settings. In the medical field, it primarily treats estrogen-related cancers such as breast cancer in women, while in sports, it helps mitigate side effects associated with estrogenic steroids, including water retention and gynecomastia in men.

This drug functions as a non-steroidal aromatase inhibitor, with Letrozole as its active ingredient. It is sanctioned for human use, being non-steroidal, devoid of androgenic properties, relatively non-toxic, and not harmful to the liver. It also does not possess narcotic or addictive qualities.

Letrozol 2.5, when ingested, acts as an aromatase inhibitor, reducing estrogen levels by 75-95% from the baseline by inhibiting the cytochrome P450 component of the aromatase enzyme. It belongs to the third generation of aromatase inhibitors, with Anastrozole as its analog—yet they function differently. Clomid and Nolvadex serve as estrogen receptor blockers, affecting receptor binding rather than estrogen production.

Letrozol 2.5 is generally considered a safe medication, with minimal side effects when used according to guidelines. However, if misused or overused, it may lead to digestive issues (like nausea and dry mouth), central nervous system effects (such as dizziness and depression), respiratory symptoms (including breathlessness and cough), and musculoskeletal problems (ranging from joint pain to osteoporosis). In cases of overdose, symptomatic treatment is recommended.

Letrozol is taken orally, independent of food, as it is rapidly and completely absorbed by the gastrointestinal tract, achieving 99% bioavailability without being affected by food intake. The typical dosage ranges from 2.5 to 5 mg per day, depending on individual needs and tolerance.

There are two common usage regimens: 1. As a preventive measure against complications from estrogenic steroids. 2. As an adjunct treatment during a steroid cycle for managing estrogen-related side effects.

Regardless of the approach, the medication effectively prevents estrogen-related side effects, such as water retention, increased body fat, and gynecomastia in men.

Before starting Letrozol 2.5, individuals should consult a healthcare professional to rule out any potential risks or contraindications. For women, contraindications include pregnancy, breastfeeding, and certain reproductive health conditions. For both sexes, allergies or hypersensitivity to the drug's ingredients and age restrictions apply, particularly in children.

Caution is warranted in patients with glucose-galactose malabsorption, lactase deficiency, and intolerance to lactase, as these may trigger adverse effects. Generally, dosing adjustments are not required.

: Keep out of reach of children. Intended for adults only.